Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
... at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute Myeloid Leukemia (AML) is a form of blood ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the ... Read More
-
Global Periodontal Therapeutics Market - 2023-2030
... therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market. The non-surgical treatment procedures for gum ... Read More
-
Global Cerebral Palsy Treatment Market - 2023-2030
... The global cerebral palsy treatment market is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030). The key players are adopting strategies such as partnerships, mergers, acquisitions, and regional expansion to stand ... Read More
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028
... healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various ... Read More
-
Global Scleroderma Market - 2023-2030
... exhibit a CAGR of 6.2% during the forecast period (2023-2030). The key market players are adopting various strategies such as product approvals, acquisitions, partnerships, and new launches to increase product reach and strengthen their product ... Read More
-
Global Artificial Intelligence-driven Drug Development Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Global Invasive Fungal Infections Market: Analysis By Molecule Class (Azoles, Echinocandins, Allylamines/Pyrimidines, Polyenes and Others), By Infection Type (Candidiasis, Aspergillosis, Cryptococcus, and Other), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... to 2028 Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep tissues, organs, or the bloodstream of the human body. These infections can occur in individuals with weakened ... Read More
-
Global Peptide Therapeutics Market Report and Forecast 2023-2031
... the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2023-2031 to achieve a value of USD 69.9 billion by 2031. Peptide Therapeutics: Introduction Peptide therapeutics ... Read More
-
Global Artificial Intelligence in Drug Discovery and Development Market Growth (Status and Outlook) 2023-2029
... to US$ 9235.1 million in 2029; it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence in Drug Discovery and Development is estimated to increase ... Read More
-
Global Central Nervous System Biomarkers Market Size study & Forecast, by Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Others) by Application (Drug Discovery and Development, Personalized Medicine, Other Applications), by End User (Diagnostic Labs, Clinics/Hospitals, Research Centers) and Regional Analysis, 2022-2029
... Research Centers) and Regional Analysis, 2022-2029 Global Central Nervous System Biomarkers Market is valued approximately at USD 4.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% ... Read More
-
Global Microbiome Therapeutics Market Size study & Forecast, by Type (FMT, Microbiome Drugs), By Application (C. difficile, Crohn's Disease, Inflammatory Bowel Disease, Diabetes, Others) and Regional Analysis, 2022-2029
... at USD 92.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 35.32% over the forecast period 2022-2029. Microbiome treatments aim to engineer the gut microbiome by applying ... Read More
-
Global Precision Medicine Market Size study & Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other Applications), and Regional Analysis, 2022-2029
... Regional Analysis, 2022-2029 Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision ... Read More
-
Global Microbiome Therapeutics Market Report and Forecast 2023-2031
... human microbiome in health and disease across the globe. The market size is anticipated to grow at a CAGR of 40.2% during the forecast period of 2023-2031 to achieve a value of USD 3462.2 million ... Read More
-
Global Software as a Medical Device Market Size study & Forecast, by Device Type (Smartphones, Laptops/Desktops, Wearable Devices) by Software Technology (Artificial Intelligence, Machine Learning), by Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Condition & Disease Management, Digital Therapeutics) and Regional Analysis, 2022-2029
... & Disease Management, Digital Therapeutics) and Regional Analysis, 2022-2029 Global Software as a Medical Device Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
Global AI In Genomics Market Size study & Forecast, by Component (Hardware, Software, Services), By Technology (Machine Learning, Computer Vision), By Functionality (Genome Sequencing, Gene Editing, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), and Regional Analysis, 2022-2029
... Diagnostics, Others), By End-use (Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Others), and Regional Analysis, 2022-2029 Global AI In Genomics Market is valued at approximately USD 341.03 million in 2021 and is anticipated to ... Read More
-
Global Ophthalmic Disease Therapeutics Market Size Study & Forecast, by Drug Class (Anti-inflammatory, Anti-invectives, Anti-VEGF and Others) by Dosage Form (Solid, Liquid and Semisolid), by Disease Indication (Glaucoma, Dry Eye Disease, Retinal Disease, Allergy & Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029
... Infections and Others), by Distribution Channel (Hospital Pharmacies, Retail & Online Pharmacies) and Regional Analysis, 2022-2029 Global Ophthalmic Disease Therapeutics Market is valued at approximately USD 31.54 billion in 2021 and is anticipated to grow ... Read More
-
Bullous pemphigoid- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Bullous ... Read More
-
Richter’s Syndrome- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Richter’s ... Read More
-
Familial Lipoprotein Lipase Deficiency - Pipeline Insight, 2023
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Cervical Intraepithelial Neoplasia- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Brain metastases- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Brain ... Read More
-
Macular Telangiectasia (MacTel) - Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
Research Assistance
